Monday, March 8, 2021

Keep Buying the Dips in These 3 Sectors

For Penny Stock Millionaires Readers:
Your subscription has changed - click here for more details.

Wall Street Daily

Keep Buying the Dips in These 3 Sectors


Recommended Link


DO NOT Buy Bitcoin (BTC) Until You See This

Read more here...

Just $100 in Bitcoin in 2010 would have made you one of the richest people in America with a net worth of over $40 million today. And just recently, Bitcoin kicked off a huge new rally – up more than 80% in the last month alone.

Now people are pouring into cryptos like we haven’t seen in years…

But don't do anything until you see this new warning.

Lou BaseneseLou Basenese

Editor and Founder, Trend Trader Daily




Dear Wall Street Daily Reader,

The market’s having a conniption right now as interest rates rise, stoking inflation concerns.

But please don’t join in on the near-sighted panic!

As I told you earlier last week, the sudden increase in 10-year Treasury yields is blinding many investors to the sobering fact that we’re simply returning to pre-pandemic levels that are normal, not dangerous.

They’ll figure it out eventually.

But while they do, I highly recommend you treat the resulting volatility as an opportunity to “buy the dip” in these three top sectors…

Semis or Die

Interestingly enough, the pandemic didn’t put a dent in innovation. Global patent filings actually increased, or were in-line with, 2019’s levels in most major countries last year.

What the heck does that have to do with anything?

Well, first of all, innovation is the new and enduring engine of economic growth in our digital world. What’s more, most new innovations involve and/or rely on semiconductors.

Or as I’ve said before, chips are the lifeblood of the current and future economy. Full stop.

Literally every major digital trend and initiative — from cybersecurity to cloud infrastructure to data management to artificial intelligence to remote work and collaboration — isn’t possible without chips.

That’s become blatantly obvious in the current environment, as the pandemic is causing a global shortage because demand is so strong.

In such a scenario, I recommend buying the front-end of the value-chain companies.

That means suppliers like Lam Research Corporation (LRCX), which sell the equipment used to make semiconductors. And technology providers like Atomera Inc. (ATOM), which enable performance and margin improvements for every type of chip.

If you want to be lazy and simply buy the semiconductor ETF, iShares PHLX Semiconductor ETF (SOXX), you should make out just fine, too.

As you can see in the chart below, the ever-growing demand for chips has led to every major dip being followed by a massive rally. For the last three years and counting.

I’d count on it again!

SOXX Chart

Recommended Link


The secrets in this book will make your landlord see red

Read more here...

But all you’ll see is green when you discover how to earn monthly income from real estate without all the hassles of being a landlord.

Over a dozen “lazy” real estate secrets ready for you to take advantage of.

Click here to find out how to claim your copy.

Biotech Boom

As a result of the pandemic, biotech is arguably the most vital sector in the world now. And rightfully so.

Without the ability to rapidly innovate as well as scale up trials and production, a single vaccine, let alone close to a half dozen of them, would still be years away.

Against this backdrop, it’s no wonder that billions in fresh capital are flooding into the sector to help propel startup biotechs to mainstream clinical success.

In terms of identifying the most compelling companies for investment, investors should focus on biotechs with “platform” technologies.

Why?

Because a single drug can only generate a finite amount of revenue. Even if it’s the top-selling drug in the world. But a biotech with a drug discovery platform can produce an endless number of drugs — and can therefore produce endless billions in potential revenue and profits.

One of my favorite biotechs involves a platform that leverages Artificial Intelligence to dramatically accelerate drug discovery, as well significantly reduce development costs. You can get all the details here.

Again, investing in a leading biotech ETF should still do the trick for those unwilling to do the work to find compelling, individual biotechs.

As you can see, the performance of the iShares Nasdaq Biotechnology ETF (IBB) has been remarkably similar to the semiconductor ETF, bouncing back quickly (and then some) following any sudden selloffs like we’re experiencing now.

IBB Chart

E-Comm All the Way

The last sector I’m extremely bullish on is not a traditional one. It’s really two trends in one — a bullish one for e-commerce, and a bearish one for traditional retail.

And that’s because the pandemic has brought about a permanent shift in consumer buying behavior. In short, we’re rapidly going from a brick-and-mortar model to click-to-order society. For everything!

But in this case, forget trying to pick individual and overvalued winners, while simultaneously figuring out which traditional retailers are destined for the courthouse steps.

We can take all the guesswork and risk out of the equation by focusing on an ETF that combines the two trends into a single investment: the ProShares Long Online/Short Stores ETF (CLIX).

And thanks to market-cap requirements (> $500 million) and monthly rebalancing, this ETF ensures we’re never overexposed to a handful of stocks. 

To go long the entire e-commerce sector, and to short the entire retail sector, this makes it as pure-play of an investment as we can get.

Stay tuned!

Ahead of the tape,

Lou Basenese

Lou Basenese
Editor and Founder, Trend Trader Daily

P.S. If you’re looking for repeatable gains, there’s only one investment I recommend…

Picture this. 

A move that can turn $500 into $1,000,000 ...even in the face of economic uncertainty...

If you’re truly interested in learning how to leverage the most explosive force in finance, then pay attention. 

Because this exclusive opportunity has the potential for hyper growth of 1,000%+...or more!

Click here to see these real world wins for yourself - and discover how to make them work for you. 

Please note, Trend Trader Daily is not affiliated with Paradigm Press.

Louis Basenese is a professional investor, and one of the country’s leading technology analysts.

He’s spent the past 20 years analyzing emerging technologies, and developing a proven methodology to consistently profit from them.

Lou began his investment career at Morgan Stanley, where he was eventually tasked with directing over $1.5 billion in capital.

Based on his proven track record as a financial analyst and investor, Lou became a television commentator on Fox Business and CNBC, and a market expert in the pages of The Wall Street Journal and Business Insider. But ultimately, Lou found he preferred helping Main Street investors like you.

By providing ordinary investors with extraordinary research, he discovered that he can help his readers change their financial futures, and change their lives for the better. And that explains why he recently launched Trend Trader Daily. 

With this new service, Lou can share his research with you on groundbreaking new technologies and emerging sectors — well before he shares this information with the general public on TV, the internet, or anywhere else.

So what's one of Lou's top recommendations for right now? Click here to see what he's recommending you do to profit in 2021 and beyond... 

Recommended Link


Biden... Boom?

Read more here...

If you're rolling the dice on a Biden boom, pay attention... 

Because new research has come to light. 

A former advisor to the CIA... and the Pentagon... 

Has just recently revealed -- on camera -- proof that Joe Biden and Kamala Harris are not equipped for reversing this crisis. Frankly, nobody in Washington is. 

Because, says this ex-insider, every last one of them is too late. 

In the fallout ahead, most stocks will collapse... the dollar could fail... 

But there's one strategy that could rebound, as high as 300% or higher over the next five years.

Find out more when you click this link.

No comments:

Post a Comment

Most important medical advance in 100 years

Artificial Intelligence is being harnessed to create breakthrough drugs no one has ever seen before. ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ...